125 related articles for article (PubMed ID: 3965151)
1. Cytotoxic activity of human pulmonary alveolar macrophages.
Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS
Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophages.
Hengst JC; Kan-Mitchell J; Kempf RA; Strumpf IJ; Sharma OP; Kortes VL; Mitchell MS
Cancer Res; 1985 Jan; 45(1):459-63. PubMed ID: 3871173
[TBL] [Abstract][Full Text] [Related]
3. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
4. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
Thomassen MJ; Wiedemann HP; Barna BP; Farmer M; Ahmad M
Cancer Res; 1988 Jul; 48(14):3949-53. PubMed ID: 2838166
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cellular cytotoxicity in blood monocytes and alveolar macrophages in patients with lung cancer.
McLennan G; Gill PG; De Young NJ
J Natl Cancer Inst; 1985 Jul; 75(1):23-7. PubMed ID: 3859693
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Robinson BW; McLemore TL; Crystal RG
J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
[TBL] [Abstract][Full Text] [Related]
7. Immunological characterization of pulmonary intravascular macrophages.
Chitko-McKown CG; Reddy DN; Chapes SK; McKown RD; Blecha F
Reg Immunol; 1992; 4(4):236-44. PubMed ID: 1476876
[TBL] [Abstract][Full Text] [Related]
8. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
Swinburne S; Cole P
J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
[TBL] [Abstract][Full Text] [Related]
10. Natural cytotoxic activity in human lungs.
Bordignon C; Villa F; Vecchi A; Giavazzi R; Introna M; Avallone R; Mantovani A
Clin Exp Immunol; 1982 Feb; 47(2):437-44. PubMed ID: 6176378
[TBL] [Abstract][Full Text] [Related]
11. [A preliminary study on the role of interleukin-1 in chronic lung disease].
Liu CT; Wang ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):221-3, 255. PubMed ID: 2090352
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
13. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
14. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
16. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
[TBL] [Abstract][Full Text] [Related]
17. Bovine monocyte-induced tumor cell cytotoxicosis.
Atluru D; Johnson DW
Am J Vet Res; 1982 Jun; 43(6):989-91. PubMed ID: 7103188
[TBL] [Abstract][Full Text] [Related]
18. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
19. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders.
Bitterman PB; Adelberg S; Crystal RG
J Clin Invest; 1983 Nov; 72(5):1801-13. PubMed ID: 6630527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
